Hot Investor Mandate: Western Europe VC Firm Looks for New Opportunities in Biotech Platform Technologies, Diagnostics, and Digital Health

7 Mar

A venture capital firm based in Western Europe with multiple funds raised to date, generally makes equity investments into internet and health tech companies at seed and early stages. The typical investment size ranges from €0.2 million to € 2 million. The firm plans to make 15-20 investments in the next 3 years and the firm will invest in companies based in Europe with a focus on Switzerland and Germany.

The firm is currently looking for new opportunities in the area of platform technologies, diagnostics, digital health, etc. The firm focuses on companies developing biotech platforms, research tools and nutrition in preclinical and clinical stages. The firm will not invest in drug development companies or medical device companies. In the past, the firm was active in companies developing proteomics platform technology, 3D micro tissues technology, diagnostic services, vaccines, and technology platform to develop virus envelopes.

The firm typically seeks to invest in private companies with convincing founders or managers. The firm will consider pre-revenue companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: